GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenith Capital Corp (OTCPK:ZHCLF) » Definitions » Total Assets

Zenith Capital (Zenith Capital) Total Assets : $0.00 Mil (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Zenith Capital Total Assets?

Zenith Capital's Total Assets for the quarter that ended in . 20 was $0.00 Mil.

Total Assets is connected with ROA %. Zenith Capital's annualized ROA % for the quarter that ended in . 20 was %. Total Assets is also linked to Revenue through Asset Turnover. Zenith Capital's Asset Turnover for the quarter that ended in . 20 was .


Zenith Capital Total Assets Historical Data

The historical data trend for Zenith Capital's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenith Capital Total Assets Chart

Zenith Capital Annual Data
Trend
Total Assets

Zenith Capital Quarterly Data
Total Assets

Zenith Capital Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Zenith Capital's Total Assets for the fiscal year that ended in . 20 is calculated as

Total Assets=Total Equity (A: . 20 )+Total Liabilities (A: . 20 )
=N/A+N/A
=N/A

Zenith Capital's Total Assets for the quarter that ended in . 20 is calculated as

Total Assets=Total Equity (Q: . 20 )+Total Liabilities (Q: . 20 )
=N/A+N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zenith Capital  (OTCPK:ZHCLF) Total Assets Explanation

Total Assets is connected with ROA %.

Zenith Capital's annualized ROA % for the quarter that ended in . 20 is

ROA %=Net Income (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

Note: The Net Income data used here is four times the quarterly (. 20) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Zenith Capital's Asset Turnover for the quarter that ended in . 20 is

Asset Turnover
=Revenue (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Zenith Capital Total Assets Related Terms

Thank you for viewing the detailed overview of Zenith Capital's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenith Capital (Zenith Capital) Business Description

Traded in Other Exchanges
N/A
Address
300, 4820 RIchard Road SW, Calgary, AB, CAN, T3E 6L1
Website
Zenith Capital Corp is a biotechnology investment company. The company operates through its wholly-owned subsidiary Zenith Epigenetics Ltd. It is a clinical-stage biotechnology company focused on discovering and developing novel therapeutics. The company is developing various novel combinations of BET inhibitors with other targeted agents. Its lead compound, ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer (mCRPC) in collaboration with Astellas and Newsoara and in metastatic triple-negative breast cancer.

Zenith Capital (Zenith Capital) Headlines

No Headlines